Japan approves updated Covid-19 vaccine to tackle JN.1 variant
CSL and Arcturus Therapeutics’s self-amplifying mRNA (sa-mRNA) vaccine, Kostaive (ARCT-154) has been approved in Japan to tackle the JN.1 strain…
News
Oncternal stock crashes by 60% as it lays off staff and scraps trials
Cidara axes 30% of staff to focus on flu prevention drug
Sobi and Enable Injections partner for Aspaveli distribution
FDA approves Roche’s Tecentriq Hybreza for cancer
Sanofi signs radioligand therapy licensing deal for rare cancers
Eli Lilly to invest $1.8bn in manufacturing capacity in Ireland
Moderna cuts five programmes to save $1.1bn in R&D costs
